Evidence supporting atogepant as a promising treatment for migraine preventionDecember 14, 2022Headache & Migraine
High drug costs exclude most neurology patients from cutting-edge treatmentDecember 5, 2022Headache & Migraine
Commentary: Risk factors and treatment for pediatric migraine, December 2022December 4, 2022Headache & Migraine
Galcanezumab reduces migraine severity and symptoms in episodic migraineNovember 21, 2022Headache & Migraine
Adenosine induces headache and short-lasting vasodilation but not migraine attacksNovember 21, 2022Headache & Migraine
Increased risk for migraine among individuals with childhood cancerNovember 21, 2022Headache & Migraine
Calcified neurocysticercosis influences disease severity and treatment response in migraineNovember 21, 2022Headache & Migraine
Do autonomic symptoms influence headache frequency and treatment response in migraine?November 21, 2022Headache & Migraine
Elevated peripheral inflammatory markers may help support migraine diagnosisNovember 21, 2022Headache & Migraine
Efficacy and safety of zolmitriptan nasal spray for acute treatment of pediatric migraineNovember 21, 2022Headache & Migraine
Zavegepant nasal spray effective and safe for acute treatment of migraineNovember 21, 2022Headache & Migraine
Increased risk for anxiety and depression in children and adolescents with migraineNovember 21, 2022Headache & Migraine
Increased risk for anxiety and depression in children and adolescents with migraineNovember 21, 2022Headache & Migraine
